Retraction notice to “In vitro angiogenic performance and in vivo brain targeting of magnetized endothelial progenitor cells for neurorepair therapies” [Nanomedicine: Nanotechnology, Biology and Medicine 10/1 (2014) 225–234, (S1549963413002736), (10.1016/j.nano.2013.06.005)];In vitro angiogenic performance and in vivo brain targeting of magnetized endothelial progenitor cells for neurorepair therapies

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 1, 2014, Pages 225-234

  Carenza, Elisa ^a   Barceló, Verónica ^b   Morancho, Anna ^b   Levander, Lisa ^a   Boada, Cristina ^b   Laromaine, Anna ^a   Roig, Anna ^a   Montaner, Joan ^b   Rosell, Anna ^b  

^a INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA ICMAB CSIC   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Angiogenesis; Endothelial progenitor cell; Growth factor; Iron oxide nanoparticle; Magnetic field guidance; MRI

Indexed keywords

CYTOLOGY; ENDOTHELIAL CELLS; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; IRON OXIDES; METAL NANOPARTICLES; NANOMAGNETICS; REPAIR;

ANGIOGENESIS; ENDOTHELIAL PROGENITOR CELLS; GROWTH FACTOR; IN-VITRO; IN-VIVO; IRON OXIDE NANOPARTICLE; MAGNETIC FIELD GUIDANCE; MAGNETIC-FIELD; PERFORMANCE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES;

MAGNETIC RESONANCE IMAGING;

MATRIGEL; REACTIVE OXYGEN METABOLITE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CELL MIGRATION; CELL THERAPY; CELL VIABILITY; CELLULAR SECRETION; CENTRAL NERVOUS SYSTEM; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOPLASM; ENDOSOME; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYSOSOME; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL TRANSDUCTION; TISSUE REPAIR; TRANSMISSION ELECTRON MICROSCOPY;

MURINAE; MUS;

ANGIOGENESIS; ENDOTHELIAL PROGENITOR CELL; GROWTH FACTOR; IRON OXIDE NANOPARTICLE; MAGNETIC FIELD GUIDANCE; MRI;

ANIMALS; BRAIN; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; FERRIC COMPOUNDS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; REACTIVE OXYGEN SPECIES; STAINING AND LABELING; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84891017144     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2024.102793     Document Type: Erratum

References (48)

1. Tissueplasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
2. Carmichael S.T. Themes and strategies for studying the biology of stroke recovery in the poststroke epoch. Stroke 2008, 39:1380-1388.
3. Chopp M., Li Y., Zhang J. Plasticity and remodeling of brain. J Neurol Sci 2008, 265:97-101.
4. Ohab J.J., Fleming S., Blesch A., Carmichael S.T. A neurovascular niche for neurogenesis after stroke. J Neurosci 2006, 26:13007-13016.
5. Ohab J.J., Carmichael S.T. Poststroke neurogenesis: emerging principles of migration and localization of immature neurons. Neuroscientist 2008, 14:369-380.
6. Pepper M.S. Manipulating angiogenesis. From basic science to the bedside. Arterioscler Thromb Vasc Biol 1997, 17:605-619.
7. Ribatti D., Vacca A., Nico B., Roncali L., Dammacco F. Postnatal vasculogenesis. Mech Dev 2001, 100:157-163.
8. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
9. Urbich C., Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 2004, 14:318-322.
10. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004, 24:288-293.
11. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712.
12. Saltzman A.J., Choi S.W., Dabreo A., Baur W.E., Weiss E., Nguyen K., et al. Endothelial progenitor cells delivered into the pericardial space incorporate into areas of ischemic myocardium. Cardiovasc Revasc Med 2010, 11:241-248.
13. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000, 97:3422-3427.
14. Foubert P., Matrone G., Souttou B., Leré-Déan C., Barateau V., Plouët J., et al. Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy. Circ Res 2008, 103:751-760.
15. + cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004, 114:330-338.
16. Fan Y., Shen F., Frenzel T., Zhu W., Ye J., Liu J., et al. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol 2010, 67:488-497.
17. Urbich C., Aicher A., Heeschen C., Dernbach E., Hofmann W.K., Zeiher A.M., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005, 39:733-742.
18. He T., Peterson T.E., Katusic Z.S. Paracrine mitogenic effect of human endothelial progenitor cells: role of interleukin-8. Am J Physiol Heart Circ Physiol 2005, 289:H968-H972.
19. Lee H.J., Kim K.S., Park I.H., Kim S.U. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS One 2007, 2:e156.
20. Horie N., Pereira M.P., Niizuma K., Sun G., Keren-Gill H., Encarnacion A., et al. Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells 2011, 29:274-285.
21. Andres R.H., Horie N., Slikker W., Keren-Gill H., Zhan K., Sun G., et al. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 2011, 134:1777-1789.
22. Li L., Jiang Q., Ding G., Zhang L., Zhang Z.G., Li Q., et al. Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J Cereb Blood Flow Metab 2010, 30:653-662.
23. Schrepfer S., Deuse T., Reichenspurner H., Fischbein M.P., Robbins M.C., Pelletier M.P. Stem cell transplantation: the lung barrier. Transplant Proc 2007, 39:573-576.
24. Fischer U.M., Harting M.T., Jimenez F., Monzon-Posadas W.O., Xue H., Savitz S.I., et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 2009, 18:683-692.
25. Harting M.T., Jimenez F., Xue H., Fischer U.M., Baumgartner J., Dash P.K., et al. Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg 2009, 110:1189-1197.
26. Billotey C., Wilhelm C., Devaud M., Bacri J.C., Bittoun J., Gazeau F. Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging. Magn Reson Med 2003, 49:646-654.
27. Syková E., Jendelová P., Herynek V. Magnetic resonance imaging of stem cell migration. Methods Mol Biol 2011, 750:79-90.
28. Nishida K., Tanaka N., Nakanishi K., Kamei N., Hamasaki T., Yanada S., et al. Magnetic targeting of bone marrow stromal cells into spinal cord: through cerebrospinal fluid. Neuroreport 2006, 17:1269-1272.
29. Kyrtatos P.G., Lehtolainen P., Junemann-Ramirez M., Garcia-Prieto A., Price A.N., Martin J.F., et al. Magnetic tagging increases delivery of circulating progenitors in vascular injury. JACC Cardiovasc Interv 2009, 2:794-802.
30. Wilhelm C., Bal L., Smirnov P., Galy-Fauroux I., Clément O., Gazeau F., et al. Magnetic control of vascular network formation with magnetically labeled endothelial progenitor cells. Biomaterials 2007, 28:3797-3806.
31. Taboada E., Rodríguez E., Roig A., Oró J., Roch A., Muller R.N. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging. Langmuir 2007, 23:4583-4588.
32. Rosell A., Arai K., Lok J., He T., Guo S., Navarro M., et al. Interleukin-1beta augments angiogenic responses of murine endothelial progenitor cells in vitro. J Cereb Blood Flow Metab 2009, 29:933-943.
33. Navarro-Sobrino M., Rosell A., Hernández-Guillamon M., Penalba A., Ribó M., Alvarez-Sabín J., et al. Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. Microvasc Res 2010, 80:317-323.
34. Wilhelm C., Gazeau F. Universal cell labelling with anionic magnetic nanoparticles. Biomaterials 2008, 29:3161-3174.
35. Mai X.L., Ma Z.L., Sun J.H., Ju S.H., Ma M., Teng G.J. Assessments of proliferation capacity and viability of New Zealand rabbit peripheral blood endothelial progenitor cells labeled with superparamagnetic particles. Cell Transplant 2009, 18:171-181.
36. Sasaki H., Tanaka N., Nakanishi K., Nishida K., Hamasaki T., Yamada K., et al. Therapeutic effects with magnetic targeting of bone marrow stromal cells in a rat spinal cord injury model. Spine (Phila Pa 1976) 2011, 36:933-938.
37. Fujioka Y., Tanaka N., Nakanishi K., Kamei N., Nakamae T., Izumi B., et al. Magnetic field-based delivery of human CD133 positive cells promotes functional recovery following rat spinal cord injury. Spine (Phila Pa 1976) 2012, 37:E768-E777.
38. Liu H.L., Hua M.Y., Yang H.W., Huang C.Y., Chu P.C., Wu J.S., et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci USA 2010, 107:15205-15210.
39. Chertok B., Moffat B.A., David A.E., Yu F., Bergemann C., Ross B.D., et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 2008, 29:487-496.
40. Song M., Kim Y.J., Kim Y.H., Roh J., Kim S.U., Yoon B.W. Using a neodymium magnet to target delivery of ferumoxide-labeled human neural stem cells in a rat model of focal cerebral ischemia. Hum Gene Ther 2010, 21:603-610.
41. Runge V.M. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging 2000, 12(2):205-213.
42. Chen R., Yu H., Jia Z.Y., Yao Q.L., Teng G.J. Efficient nano iron particle-labeling and noninvasive MR imaging of mouse bone marrow-derived endothelial progenitor cells. Int J Nanomedicine 2011, 6:511-519.
43. Yang J.X., Tang W.L., Wang X.X. Superparamagnetic iron oxide nanoparticles may affect endothelial progenitor cell migration ability and adhesion capacity. Cytotherapy 2010, 12:251-259.
44. Chung T.H., Hsiao J.K., Hsu S.C., Yao M., Chen Y.C., Wang S.W., et al. Iron oxide nanoparticle-induced epidermal growth factor receptor expression in human stem cells for tumor therapy. ACS Nano 2011, 5:9807-9816.
45. Ushio-Fukai M., Alexander R.W. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 2004, 264:85-97.
46. Zhu M.T., Wang Y., Feng W.Y., Wang B., Wang M., Ouyang H., et al. Oxidative stress and apoptosis induced by iron oxide nanoparticles in cultured human umbilical endothelial cells. J Nanosci Nanotechnol 2010, 10:8584-8590.
47. 2 in rat heart endothelial cells. Free Radic Biol Med 1998, 25:891-897.
48. Lamalice L., Le Boeuf F., Huot J. Endothelial cell migration during angiogenesis. Circ Res 2007, 100:782-794.